Modulation of the Immune Response Through 4-1BB
- 1 January 2002
- book chapter
- Published by Springer Nature
- Vol. 465, 355-362
- https://doi.org/10.1007/0-306-46817-4_30
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayEuropean Journal of Immunology, 1998
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- 4-1BB Is Expressed on CD45RAhiROhiTransitional T Cell in HumansCellular Immunology, 1996
- Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.The Journal of Experimental Medicine, 1996
- A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor familyGene, 1995
- Can Co-stimulated Tumor Immunity be Therapeutically Efficacious?Immunological Reviews, 1995
- Regulation of 4‐1BB expression by cell‐cell interactions and the cytokines, interleukin‐2 and interleukin‐4European Journal of Immunology, 1995
- Functional analysis of T-cell antigen 4-1BB in activated intestinal intra-epithelial T lymphocytesImmunology Letters, 1994
- Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorEuropean Journal of Immunology, 1993
- Expression characteristics of two potential T cell mediator genesCellular Immunology, 1989